ArticleJCO global oncology2022
Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database.
Yusuke Kajimoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it